Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Gainesville, FL
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Orlando, FL
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
University Park, FL
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
University Park, FL
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Smyrna, GA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Libertyville, IL
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Libertyville, IL
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Rochester Hills, MI
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Omaha, NE
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Las Vegas, NV
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Memphis, TN
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Lake Jackson, TX
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Lubbock, TX
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Lubbock, TX
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Herndon, VA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Herndon, VA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Kelowna,
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Kelowna,
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Breastlink Med Group Inc
mi
from
Long Beach, CA
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Breastlink Med Group Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Multiple Sclerosis Center at UCSF
mi
from
San Francisco, CA
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Multiple Sclerosis Center at UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Raleigh Neurology Associates
mi
from
Raleigh, NC
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Neurology and Neuroscience Associates
mi
from
Akron, OH
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Neurology and Neuroscience Associates
mi
from
Akron, OH
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Hope Neurology MS Center
mi
from
Knoxville, TN
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Hope Neurology MS Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Central Texas Neurology Consultants, P.A.
mi
from
Round Rock, TX
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Central Texas Neurology Consultants, P.A.
mi
from
Round Rock, TX
Click here to add this to my saved trials
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  3/26/2018
Loma Linda University Health
mi
from
Loma Linda, CA
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 3/26/2018
Loma Linda University Health
mi
from
Loma Linda, CA
Click here to add this to my saved trials
fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI
fMRI-neuronavigated Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depression Associated With Traumatic Brain Injury
Status: Enrolling
Updated:  3/26/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI
fMRI-neuronavigated Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depression Associated With Traumatic Brain Injury
Status: Enrolling
Updated: 3/26/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status: Enrolling
Updated:  3/27/2018
Veterans Affairs Medical Center
mi
from
Omaha, NE
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status: Enrolling
Updated: 3/27/2018
Veterans Affairs Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status: Enrolling
Updated:  3/27/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status: Enrolling
Updated: 3/27/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain
Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain
Status: Enrolling
Updated:  3/27/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain
Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain
Status: Enrolling
Updated: 3/27/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
Status: Enrolling
Updated:  3/27/2018
Boston Children's Hospital at Waltham
mi
from
Waltham, MA
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
Status: Enrolling
Updated: 3/27/2018
Boston Children's Hospital at Waltham
mi
from
Waltham, MA
Click here to add this to my saved trials
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Status: Enrolling
Updated:  3/27/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Status: Enrolling
Updated: 3/27/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Meditation in Veterans With PTSD and Mild TBI
Neuroimaging Meditation Therapy in Veterans With Co-Morbid TBI and PTSD
Status: Enrolling
Updated:  3/27/2018
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Meditation in Veterans With PTSD and Mild TBI
Neuroimaging Meditation Therapy in Veterans With Co-Morbid TBI and PTSD
Status: Enrolling
Updated: 3/27/2018
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients
Minocycline in Acute Cerebral Hemorrhage (MACH) Trial
Status: Enrolling
Updated:  3/28/2018
Georgia Health Sciences University
mi
from
Augusta, GA
A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients
Minocycline in Acute Cerebral Hemorrhage (MACH) Trial
Status: Enrolling
Updated: 3/28/2018
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Electronic-health Application To Measure Outcomes REmotely Clinical Trial
Electronic-health Application To Measure Outcomes REmotely Clinical Trial
Status: Enrolling
Updated:  3/28/2018
Massachusetts General Hospital
mi
from
Boston, MA
Electronic-health Application To Measure Outcomes REmotely Clinical Trial
Electronic-health Application To Measure Outcomes REmotely Clinical Trial
Status: Enrolling
Updated: 3/28/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Florida Hospital
mi
from
Orlando, FL
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Emory University
mi
from
Atlanta, GA
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
UTHealth Science Center
mi
from
Houston, TX
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
UTHealth Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
WellStar Health System
mi
from
Marietta, GA
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
WellStar Health System
mi
from
Marietta, GA
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
St. Louis University
mi
from
Saint Louis, MO
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
St. Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Riverside Methodist Hospital
mi
from
Columbus, OH
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Valley Baptist Medical Center
mi
from
Harlingen, TX
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Valley Baptist Medical Center
mi
from
Harlingen, TX
Click here to add this to my saved trials
Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
A Study of the Natural History of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
Status: Enrolling
Updated:  3/28/2018
Indiana University Health Hospital
mi
from
Indianapolis, IN
Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
A Study of the Natural History of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
Status: Enrolling
Updated: 3/28/2018
Indiana University Health Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
A Study of the Natural History of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
Status: Enrolling
Updated:  3/28/2018
Indiana University Health Melvin And Bren Simon Cancer Center
mi
from
Indianapolis, IN
Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
A Study of the Natural History of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
Status: Enrolling
Updated: 3/28/2018
Indiana University Health Melvin And Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
A Study of the Natural History of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
Status: Enrolling
Updated:  3/28/2018
Mayo Clinic Department of Medical Oncology
mi
from
Rochester, MN
Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
A Study of the Natural History of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
Status: Enrolling
Updated: 3/28/2018
Mayo Clinic Department of Medical Oncology
mi
from
Rochester, MN
Click here to add this to my saved trials
Effect of Tetrabenazine on Stroop Interference in HD
Effect of Tetrabenazine on Stroop Interference in Huntington Disease
Status: Enrolling
Updated:  3/29/2018
Terence Cardinal Cooke Health Care Center
mi
from
New York, NY
Effect of Tetrabenazine on Stroop Interference in HD
Effect of Tetrabenazine on Stroop Interference in Huntington Disease
Status: Enrolling
Updated: 3/29/2018
Terence Cardinal Cooke Health Care Center
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Status: Enrolling
Updated:  3/29/2018
University of California, Los Angeles Neurology Clinic
mi
from
Los Angeles, CA
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Status: Enrolling
Updated: 3/29/2018
University of California, Los Angeles Neurology Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Status: Enrolling
Updated:  3/29/2018
University of Florida Clinical Research Center
mi
from
Gainesville, FL
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Status: Enrolling
Updated: 3/29/2018
University of Florida Clinical Research Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Status: Enrolling
Updated:  3/29/2018
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Status: Enrolling
Updated: 3/29/2018
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Status: Enrolling
Updated:  3/29/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Status: Enrolling
Updated: 3/29/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Trichuris Suis Ova in Autism Spectrum Disorders
Trichuris Suis Ova in Autism Spectrum Disorders
Status: Enrolling
Updated:  3/30/2018
Montefiore Medical Center, Albert Einstein College of Medicine
mi
from
Bronx, NY
Trichuris Suis Ova in Autism Spectrum Disorders
Trichuris Suis Ova in Autism Spectrum Disorders
Status: Enrolling
Updated: 3/30/2018
Montefiore Medical Center, Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Cervical Spondylotic Myelopathy Surgical Trial
Cervical Spondylotic Myelopathy Surgical Trial
Status: Enrolling
Updated:  3/30/2018
University of California at San Francisco
mi
from
San Francisco, CA
Cervical Spondylotic Myelopathy Surgical Trial
Cervical Spondylotic Myelopathy Surgical Trial
Status: Enrolling
Updated: 3/30/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cervical Spondylotic Myelopathy Surgical Trial
Cervical Spondylotic Myelopathy Surgical Trial
Status: Enrolling
Updated:  3/30/2018
Emory
mi
from
Atlanta, GA
Cervical Spondylotic Myelopathy Surgical Trial
Cervical Spondylotic Myelopathy Surgical Trial
Status: Enrolling
Updated: 3/30/2018
Emory
mi
from
Atlanta, GA
Click here to add this to my saved trials